BROWSE ALL ARTICLES BY TOPIC
RELATED ITEMS
From: The Rheumatologist, August 2012
Features
High-Impact Rheumatology Practice Redesign
It’s time to start adapting your practice to changes in the healthcare system.
Where the Presidential Candidates Stand on Key Healthcare Issues
Where President Obama and and Republican presidential candidate Mitt Romney stand on healthcare issues affecting rheumatologists and the medical profession as a whole.
more Features
News
Educational Leader Honored with Top Rheumatology Award
Paul Emery, MA, MD, receives prestigious Nachman Prize.
more News
From the College
AMA House of Delegates Meeting: Decisions Affecting You
An overview of some of the issues that were covered during the June 2012 American Medical Association House of Delegates meeting to debate policy.
American College of Rheumatology Benchmark Survey Now in Progress
This comprehensive study is being conducted to determine benchmarks for rheumatology in an era of increased numbers of uninsured and underinsured patients in the general population, increased chronic and musculoskeletal diseases, and an expanding population of aging citizens.
Outstanding ARHP Program Planned for the ACR/ARHP Annual Meeting
The primary tracks at the meeting will focus on clinical practice, clinical science, basic science, and business/administration; four subtracks will include sessions relevant for educators, those interested in pediatrics, practice managers, and rheumatology trainees.
Care of Rheumatologist Leads Patient to Give Back
After his rheumatologist helped him get back on his feet, Craig Plumhoff got involved with the ACR Research and Education Foundation to help others like him.
American College of Rheumatology Leads Charge to Address Excessive Patient Cost Sharing
The ACR Government Affairs Committee has developed legislative language to limit commercial insurance plans' cost-sharing requirements for medications in a specialty drug tier to the dollar amount applicable to drugs in the nonpreferred-brand drug tier.
Coding Corner Question: August Coding Challenge
A 43-year-old female established patient diagnosed with rheumatoid arthritis comes to the office for her first infliximab infusion.
Managing an In-Office Infusion Practice
The increased utilization of infusible biologics for the treatment of rheumatic diseases has opened the door for you to provide more integrated care for your patients. Having an in-office infusion center gives you the ability to deliver this service to your patients in a familiar and supportive setting.
more From the College
Departments
Coding Corner Answer: August Coding Challenge
A 43-year-old female established patient diagnosed with rheumatoid arthritis comes to the office for her first infliximab infusion.
Patient Access to Medical Records: How Much Is Too Much?
The easy access to medical records stemming from technological advances has given rise to questions about the medical benefits to such easy access, questions now being explored by researchers in the U.S. and Europe.
Drug Updates: EULAR 2012
Tracking the results of drug safety and efficacy
Physician Texting Could Violate HIPAA
HIPAA requires that healthcare providers maintain administrative, physical, and technical safeguards to protect patient information. This safeguard requirement has many physicians’ attorneys worried that their clients are violating HIPAA on a regular basis.
Letter: No European Consensus on Steroid Use in Rheumatoid Arthritis
There is not a consensus between all European rheumatologists regarding the use of steroids in RA; quite a few share your skepticism, including myself.
more Departments
Columns
Partners in Advancing Rheumatology
The REF is making great strides in advancing treatment and finding cures for rheumatic disease.
Learning How To Look
First impressions and presumptions can lead us astray if we don’t pay attention.
The American Board of Bada Bing
CME, recertification—what really gets quality results?
more Columns
Meeting
EULAR 2012: Remission the New Normal for Rheumatoid Arthritis
Advances in the rheumatology clinic are promising, two experts say.
EULAR 2012: Systemic Sclerosis That Doesn't Fit the Mold
This disease presents a range of hard-to-solve clinical difficulties.
EULAR 2012: Does Arthritis Start in the Gut?
New research on the ties between bacteria and inflammatory disease.
